Nerivio Long-term Usage in Patients With Migraine

CompletedOBSERVATIONAL
Enrollment

244

Participants

Timeline

Start Date

December 1, 2024

Primary Completion Date

December 20, 2024

Study Completion Date

December 22, 2024

Conditions
MigraineAcute Treatment of Migraine
Interventions
DEVICE

Nerivio

Remote electrical neuromodulation (REN) wearable device for the treatment of migraine. The device delivers electrical stimulation to the upper arm to induce conditioned pain modulation (CPM) that activates a descending endogenous analgesic mechanism. The treatment is self-administered and controlled by a smartphone application.

Trial Locations (1)

08807

Theranica Bio-Elewctronics Inc, Bridgewater

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Theranica

INDUSTRY

NCT06738056 - Nerivio Long-term Usage in Patients With Migraine | Biotech Hunter | Biotech Hunter